Iovance Biotherapeutics Inc (NASDAQ:IOVA)

20.94
Delayed Data
As of Sep 20
 +0.22 / +1.06%
Today’s Change
7.26
Today|||52-Week Range
26.59
+136.61%
Year-to-Date
No recent news for Iovance Biotherapeutics Inc.

Today’s Trading

Previous close20.72
Today’s open20.90
Day’s range20.66 - 21.67
Volume4,799,867
Average volume (3 months)1,858,424
Market cap$2.7B
Data as of 3:59pm ET, 09/20/2019

Growth & Valuation

Earnings growth (last year)+9.90%
Earnings growth (this year)-17.67%
Earnings growth (next 5 years)-19.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.68

Competitors

 Today’s
change
Today’s
% change
EBSEmergent BioSolution...-0.99-1.90%
CRSPCRISPR Therapeutics ...+0.82+1.73%
ARWRArrowhead Pharmaceut...-0.23-0.79%
HALOHalozyme Therapeutic...+0.08+0.49%
Data as of 6:30pm ET, 09/20/2019

Financials

Next reporting dateNovember 1, 2019
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$0.00
Annual profit (last year)-$123.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Maria Fardis
Secretary, Chief Financial &
Accounting Officer
Timothy E. Morris
Corporate headquarters
San Carlos, California

Forecasts